We are very happy to have completed a new installation of a research HIFU system at the Wellman Center for Photomedicine at Massachusetts General Hospital / Harvard Medical School.
The world-leading team there will use the system to test new non-invasive treatment modalities, and in particular therapy solutions for cutaneous neurofibromas in people living with Neurofibromatosis Type 1 (also known as von Recklinghausen’s disease). The work forms a part of the activities coordinated by the Neurofibromatosis Therapeutic Acceleration Program at Johns Hopkins University School of Medicine.
For TOOsonix, this is what it is all about. Using our technology to help people with symptomatic tumors that often result in significant disfigurement and pain, and where surgery is the only standard of care, is definitely a worthy cause by any measure.
We wish the research teams at Harvard and Johns Hopkins the best of luck with their research work and will support them as much as we possibly can.
